{"id":44803,"date":"2022-06-07T17:01:26","date_gmt":"2022-06-07T15:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/"},"modified":"2022-06-07T17:01:26","modified_gmt":"2022-06-07T15:01:26","slug":"paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/","title":{"rendered":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress"},"content":{"rendered":"
\n

\nWith clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress<\/i>\n<\/p>\n

<\/a><\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc.<\/a>, a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in Boston, Massachusetts. Since the commercial introduction of the LIVERguard system in January 2022, the advanced donor organ preservation system has been utilized at 8 U.S. transplant centers, including UF Health Shands<\/a>, one of the largest liver transplant centers in the world. Additionally, Paragonix has been partnering with numerous Organ Procurement Organizations in order to provide more access to this unique hypothermic preservation technology.\n<\/p>\n

\nThe LIVERguard\u2122 System provides a highly controlled, state-of-the art environment for hypothermic liver preservation, coupled with real-time digital monitoring to safeguard a donor liver throughout the transplant journey from donation to transplantation. Like all Paragonix systems<\/a>, the LIVERguard\u2122 System is paired with a comprehensive digital offering that permits organ tracking, organ monitoring, and the capture of clinical milestones.\n<\/p>\n

\nThis expanded adoption of the LIVERguard system aligns with the first enrollments of the GUARDIAN-LIVER global clinical registry, a comprehensive study that seeks to evaluate a missing piece of the organ procurement process: the impact of methods and technologies used for liver preservation and transportation, and their contribution to the clinical outcome and success of transplant surgery. Patient enrollment in GUARDIAN-LIVER has initiated and Paragonix plans to provide an initial report of the registry\u2019s findings before the end of the year.\n<\/p>\n

\n\u201cWe are excited by the clinical feedback received to date, and we are looking forward to support Liver Transplant Centers transition from an outdated ice-based storage method to our state-of-the art technology offering captured by LIVERguard,\u201d said Lisa Anderson, PhD, President & CEO of Paragonix. \u201cWe believe that the clinical community has identified ice transport as a severe limitation to the quality of their critical care and we are positioned to offer a predictable and measurable solution to liver preservation. With the ever-expanding enrollment in the GUARDIAN-Liver Registry, we hope to replicate the exciting results recently announced of our GUARDIAN Heart Study, including a demonstrated improvement 1-Year Survival compared to ice storage<\/a>, and continue to demonstrate the benefits of advanced organ preservation.\u201d1<\/sup>\n<\/p>\n

\nFor more information about Paragonix, visit www.paragonix.com<\/a><\/span>.\n<\/p>\n

\nAbout Paragonix Technologies<\/b>\n<\/p>\n

\nParagonix Technologies<\/a> markets organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix is a leading provider of FDA cleared and CE marked transport devices for organ preservation.\n<\/p>\n

\nFollow us on Twitter: @ParagonixSherpa<\/a>\n<\/p>\n

\nConnect with us on LinkedIn: Paragonix Technologies<\/a>\n<\/p>\n

\nLike Us on Facebook: Paragonix SherpaPak<\/a>\n<\/p>\n

\nReferences
\n
<\/b>1. Leacche et al., ISHLT Presentation 2022, Data on file\n<\/p>\n

\nL-355, Rev 0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Adam Lafreniere, Director, Marketing Operations
\n
marketing@paragonixtechnologies.com<\/a><\/span>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44803","6":"format-standard","7":"category-industry"},"yoast_head":"\nParagonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T15:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress\",\"datePublished\":\"2022-06-07T15:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/\"},\"wordCount\":500,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005599\\\/en\\\/1194317\\\/21\\\/Blue_Logo_with_Tagline.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/\",\"name\":\"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005599\\\/en\\\/1194317\\\/21\\\/Blue_Logo_with_Tagline.jpg\",\"datePublished\":\"2022-06-07T15:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005599\\\/en\\\/1194317\\\/21\\\/Blue_Logo_with_Tagline.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005599\\\/en\\\/1194317\\\/21\\\/Blue_Logo_with_Tagline.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/","og_locale":"en_US","og_type":"article","og_title":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend","og_description":"With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-07T15:01:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress","datePublished":"2022-06-07T15:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/"},"wordCount":500,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/","url":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/","name":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg","datePublished":"2022-06-07T15:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220607005599\/en\/1194317\/21\/Blue_Logo_with_Tagline.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/paragonix-technologies-announces-expanded-adoption-of-their-liverguard-system-at-the-2022-american-transplant-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Paragonix Technologies Announces Expanded Adoption of their LIVERguard\u2122 System at the 2022 American Transplant Congress"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44803"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44803\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}